期刊文献+

胱抑素C和心血管疾病危险因素的关系 被引量:2

Cystatin C and cardiovascular risks
下载PDF
导出
摘要 半胱氨酸蛋白酶抑制剂(简称胱抑素C)是评价肾小球功能-肾小球滤过率最理想的指标之一。目前发现,胱抑素C与心血管疾病的发生及预后有密切关系。现就胱抑素C与心血管疾病危险关系的相关性做以下综述。 Cystatin C has been tion rate (GFR). Patients with cardiovascular risk profile. This vascular risks. Higher circulating indicator of assessing renal function glomemlar filtra- cystatin C concentrations appear to have an increased report presents a review of the role of cystatin C as a predictor of cardio-
出处 《心脏杂志》 CAS 2013年第2期250-252,F0003,共4页 Chinese Heart Journal
关键词 胱抑素C 心血管疾病 危险因素 cystatin C cardiovascular disease atherosclerosis
  • 相关文献

参考文献12

  • 1Suzuki Y, Matsushita K, Yoshida T, et al. Clinical validity of renalfunction markers including serum cystatinC on chronic kidney dis-ease classificatio[ J]. Rinsho Byori, 2011,59(4) :345 -351.
  • 2Coresh J, Selvin E, Stevens LA, et. al. Prevalence of chronic kidneydisease in the united states [ J ] . JAMA, 2007 , 298 ( 17) : 2038 -2047.
  • 3Zahran A, Qureshi M,Shoker A. Comparision between creatinineand cystatin C-hased GFR equations in renal transplantation [ J ].Nephrol Dial Transplant, 2007,22(9) :2657 - 2668.
  • 4Barka T, van der Noen H. Expression of the cysteine proleinase in-hibitor cystatin C gene in rat heart : use of digoxigenin labeledprobes generated by polymerase chain reaction directJy for in situ andnorthern blot hybridizations [ J ]. J Histochem Cytochem , 1993,41(12):1863 -1867.
  • 5Parikh NI, Hwang SJ, Yang Q, et al. Clinical correlates and lierita-bility of cystatin C ( from the Framingham Offspring Study) [ J]. AmJ Cardiol, 2008, 102(9):1194 -1198.
  • 6Muntner P, Mann D, Winston J, et al. Seruin cystatin C ami in-creasecl coronary heart disease prevalence in US adults without c-hro-nic kidney disease[ J]. Am J Cardiol, 2008,102( 1) :54 -57.
  • 7Keslenhaum B, Rudser KD, de Boer IH, et al. Differences in kid-ney function and incident hypertension: the multiethnic study of ath-erosclerosis[ J]. Ann intern Med, 2008, 148(7) :501 -508.
  • 8葛长江,任芳,吕树铮,柳弘,宋现涛,陈欣,孟康,吴小凡,苑飞,金泽宁,李红,季凤清.血浆胱抑素C对冠心病的临床预测价值[J].中华急诊医学杂志,2010,19(3):273-276. 被引量:45
  • 9刘玉胜,鹿庆华,蒋卫东,杜贻盟,王永梅,张华岩,王欣,徐冬玲,郝琳,盛林,王群,秦爱琼.血清组织蛋白酶S、胱抑素C水平与冠状动脉粥样硬化病变严重程度相关性的研究——附107例报告[J].新医学,2008,39(4):219-221. 被引量:19
  • 10王超权,徐耕,程刚.血清胱抑素C水平对缺血性心力衰竭患者近期预后的影响[J].中国循环杂志,2009,24(1):28-31. 被引量:49

二级参考文献18

  • 1J Am Coll Cardiol,张伟丽.CRP与斑块破裂有关[J].中国分子心脏病学杂志,2005,5(3):546-546. 被引量:78
  • 2徐峰,陈玉国,孙祎,李瑞建,刘春喜,陈文强,徐新生,张运.建立动脉粥样硬化蚀损斑块模型的实验研究[J].中华急诊医学杂志,2006,15(12):1085-1088. 被引量:2
  • 3Filler G,Bokenkamp A,Hofmann W,et al.Cystatin C as a marker of GFR history,Indications and future research[J].Clin Biochem,2005,38(1):1-8.
  • 4Sarnak MJ,Katz R,Stehman-Breon CO,et al.Cystatin C concentration as a risk factor for heart failure in older adults.Ann Intern Med,2005,142(7):497-505.
  • 5陈灏珠译.心脏病学[M].第5版.北京:人民卫生出版社,2003.407-411.
  • 6Barka T,van der Noon H.Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart:use of digoxi-genin-labeled probes generated by polymerase chain reaction directly for in situ and northem blot hybridizations.J Histochem Cytochem,1993,41:1863-1867.
  • 7Bostom AG,Bausserman L,Jacques PF,et al.Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.Arterioscler Thromb Vasc Biol,1999,19:2241-2244.
  • 8Sc hiffrin EL,Lipman ML,Mann JF.Chronic kidney disease:effects on the cardiovascular system.Circulation,2007,116:85-97.
  • 9Lassus J,Harjola VP,Sund R,et al.Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.Eur Heart J,2007,28(15):1841-1847.
  • 10Ix JH,Shlipak MG,Chertow GM,et al.Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease:data from the Heart and Soul Study.Circulation,2007,115:173-179.

共引文献104

同被引文献18

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部